Literature DB >> 15714922

Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?

P Hatfield1, A Merrick, K Harrington, R Vile, A Bateman, P Selby, A Melcher.   

Abstract

Dendritic cells are key orchestrators of the immune system. There is considerable interest in their use for treating cancer. Whether they initiate an effective cytotoxic response against antigen-bearing cells, or produce tolerance, depends on the context in which those antigens are presented. Ionising radiation, and the cell death it causes, has several properties that may facilitate such an effective response. A range of in-vitro and in-vivo data supports this, although potential problems exist that may require concurrent strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714922     DOI: 10.1016/j.clon.2004.06.014

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  10 in total

1.  Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.

Authors:  Paul Hatfield; Alison E Merrick; Emma West; Dearbhaile O'Donnell; Peter Selby; Richard Vile; Alan A Melcher
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

2.  Anti-angiogenesis immunotherapy.

Authors:  Jonathan D Schoenfeld; Glenn Dranoff
Journal:  Hum Vaccin       Date:  2011-09-01

3.  Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cells.

Authors:  Yuru Meng; Helena J Mauceri; Nikolai N Khodarev; Thomas E Darga; Sean P Pitroda; Michael A Beckett; Donald W Kufe; Ralph R Weichselbaum
Journal:  Mol Ther       Date:  2010-03-02       Impact factor: 11.454

4.  A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Authors:  Jonathan D Schoenfeld; Danielle N Margalit; Julie L Kasperzyk; Irene M Shui; Jennifer R Rider; Mara M Epstein; Allison Meisner; Stacey A Kenfield; Neil E Martin; Paul L Nguyen; Philip W Kantoff; Edward L Giovannucci; Meir J Stampfer; Lorelei A Mucci
Journal:  Clin Cancer Res       Date:  2013-02-04       Impact factor: 12.531

5.  Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.

Authors:  Youjin Lee; Sogyong L Auh; Yugang Wang; Byron Burnette; Yang Wang; Yuru Meng; Michael Beckett; Rohit Sharma; Robert Chin; Tony Tu; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  Blood       Date:  2009-04-06       Impact factor: 22.113

6.  Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.

Authors:  Molykutty J Aryankalayil; Adeola Y Makinde; Sofia R Gameiro; James W Hodge; Patricia P Rivera-Solis; Sanjeewani T Palayoor; Mansoor M Ahmed; C Norman Coleman
Journal:  Radiat Res       Date:  2014-07-08       Impact factor: 2.841

7.  Protective effect on normal brain tissue during a combinational therapy of 2-deoxy-d-glucose and hypofractionated irradiation in malignant gliomas.

Authors:  Neelam K Venkataramanaa; P K Venkatesh; B S Dwarakanath; S Vani
Journal:  Asian J Neurosurg       Date:  2013-01

Review 8.  A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy.

Authors:  Shuyan Li; Xiao Chu; Luxi Ye; Jianjiao Ni; Zhengfei Zhu
Journal:  Transl Lung Cancer Res       Date:  2020-10

9.  The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines.

Authors:  Donna H Deacon; Kevin T Hogan; Erin M Swanson; Kimberly A Chianese-Bullock; Chadrick E Denlinger; Andrea R Czarkowski; Randy S Schrecengost; James W Patterson; Mark W Teague; Craig L Slingluff
Journal:  BMC Cancer       Date:  2008-12-04       Impact factor: 4.430

Review 10.  Immunomodulatory Effects of Radiotherapy.

Authors:  Sharda Kumari; Shibani Mukherjee; Debapriya Sinha; Salim Abdisalaam; Sunil Krishnan; Aroumougame Asaithamby
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.